| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Stanley Frankel | Director | 2025-09-26 | 2,700 | $4.97 | $13.42kBuy |
| Melinda Brown | Director | 2025-09-22 | 1,400 | $4.89 | $6.85kBuy |
| John Alexander Kelly | Chief Financial Officer | 2025-07-03 | 14,827 | $4.26 | $63.16kSell |
| Melinda Brown | Director | 2025-06-25 | 1,682 | $4.14 | $6.96kBuy |
| Kevin Buehler | Director | 2025-06-25 | 5,076 | $4.16 | $21.12kBuy |
| Kevin Buehler | Director | 2025-03-26 | 4,523 | $4.67 | $21.12kBuy |
| Melinda Brown | Director | 2025-03-26 | 1,839 | $4.75 | $8.74kBuy |
| Geno J. Germano | Director | 2025-03-25 | 3,250 | $5.30 | $17.23kBuy |
| Michael Amoroso | President and CEO | 2025-03-24 | 964 | $5.56 | $5.36kSell |
| J. Jefferson Smith | Chief Research Officer | 2025-03-04 | 154 | $4.91 | $756.14Sell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Pharma Ag Novartis | 111.90% | 12,407,440 | $85.98M | Insider |
| Venbio Global Strategic Fund LP | 38.47% | 4,265,141 | $29.56M | Insider |
| Derek Jantz | 36.57% | 4,055,174 | $28.10M | Insider |
| Fmr LLC | 33.71% | 3,738,248 | $25.91M | Insider |
| Matthew R. Kane | 18.26% | 2,024,438 | $14.03M | Insider |
| Bleichroeder LP | 9.69% | 1,075,000 | $7.45M | Institution |
| Lynx1 Capital Management LP | 9.34% | 1,036,051 | $7.18M | Institution |
| Tang Capital Management LLC | 5.89% | 653,649 | $4.53M | Institution |
| Vanguard Group Inc | 3.66% | 405,354 | $2.81M | Institution |
| Acadian Asset Management LLC | 2.04% | 225,937 | $1.57M | Institution |